Carolyn Tze Ing Loh

Universiti Malaya

H指数:3

被引数:36

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal changes of skeletal muscle mass and architecture in critically ill adults: A prospective matched cohort study

危重症成人骨骼肌质量和结构的纵向变化：一项前瞻性匹配队列研究

Journal of Parenteral and Enteral Nutrition

IF4.1

2026-08-190

PRE

Association of energy and protein delivery with mortality in critically ill patients with low muscularity assessed by computed tomography: A single-center retrospective study

通过计算机断层扫描评估肌肉量减少的危重患者中，能量和蛋白质供给与死亡率的关联性：一项单中心回顾性研究

clinical nutrition

IF2.6

2025-07-170

PRE

Epidemiology and long-term outcomes of critically ill patients with severe AKI in India and Southeast Asia

印度和东南亚危重患者中严重AKI的流行病学和长期预后

Intensive Care Medicine

IF21.2

2025-07-140

PRE

Suri Tangchitthavorngul; Nuttha Lumlertgul; Sadudee Peerapornratana; Anh Tuan Mai; Mohd Shahnaz Hasan; Carolyn Tze Ing Loh; Girish V. Kumthekar; Rajasekara Chakravarthi; Jonny Jonny; Abdul Halim Abdul Gafor; Watanyu Parapiboon; Veerapatr Nimkietkajorn; Sompote Intarak; Theerapon Sukmark; Kamol Khositrangsikun; Petchdee Oranrigsupak; Atchara Aksornrat; Mohd Zulfakar Mazlan; Anan Chuasuwan; Kamonwan Tangvoraphonkchai; Thao T. N. Pham; Tien D. Truong; Linh T. Tran; Viet Ha T. Truong; Ly T. Dinh; Bach X. Nguyen; Ngan Hoang Kim Trieu; Yen H. Le; Duy L. M. Nguyen; Noot Sengthavisouk; Karjbundid Surasit; Pichaya Tantiyavarong; Wanjak Pongsittisak; Phu Nguyen Trong Tran; Kriang Tungsanga; Yingyos Avihingsanon; Nattachai Srisawat

Association of muscularity status with clinical and physical function outcomes in critically ill patients with COVID-19: A systematic review and meta-analysis

COVID-19重症患者肌肉状态与临床及身体功能结局的关联：一项系统综述和Meta分析

JOURNAL OF PARENTERAL AND ENTERAL NUTRITION

IF4.1

2025-05-110

PRE

Benefits and harm of probiotics and synbiotics in adult critically ill patients. A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis

益生菌和合生元对成人重症患者的益处和危害。随机对照试验序贯分析的系统评价和meta分析

CLINICAL NUTRITION

IF7.4

2023-04-0113

PRE